BlackRock Fund Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $189K | Buy |
44,361
+1,484
| +3% | +$6.32K | ﹤0.01% | 3437 |
|
2016
Q3 | $214K | Sell |
42,877
-59
| -0.1% | -$294 | ﹤0.01% | 3427 |
|
2016
Q2 | $152K | Buy |
42,936
+10,390
| +32% | +$36.8K | ﹤0.01% | 3556 |
|
2016
Q1 | $112K | Sell |
32,546
-2,488
| -7% | -$8.56K | ﹤0.01% | 3642 |
|
2015
Q4 | $119K | Buy |
35,034
+1,552
| +5% | +$5.27K | ﹤0.01% | 3692 |
|
2015
Q3 | $174K | Sell |
33,482
-884
| -3% | -$4.59K | ﹤0.01% | 3531 |
|
2015
Q2 | $234K | Sell |
34,366
-259,237
| -88% | -$1.77M | ﹤0.01% | 3464 |
|
2015
Q1 | $2.1M | Buy |
293,603
+1,356
| +0.5% | +$9.68K | ﹤0.01% | 3120 |
|
2014
Q4 | $2.18M | Buy |
292,247
+40,177
| +16% | +$299K | ﹤0.01% | 3151 |
|
2014
Q3 | $2.33M | Sell |
252,070
-10,481
| -4% | -$97K | ﹤0.01% | 3100 |
|
2014
Q2 | $4.89M | Buy |
262,551
+26,364
| +11% | +$491K | ﹤0.01% | 2845 |
|
2014
Q1 | $4.38M | Buy |
+236,187
| New | +$4.38M | ﹤0.01% | 2909 |
|